Evidence mapPaperPMID 38805513Full record

ArticlePloS one2024

Etiologies underlying subtypes of long-standing type 2 diabetes.

Riad Bayoumi, Muhammad Farooqi, Fatheya Alawadi, Mohamed Hassanein, Aya Osama, Debasmita Mukhopadhyay, Fatima Abdul, Fatima Sulaiman, Stafny Dsouza, Fahad Mulla and 3 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes.International journal of molecular sciences · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Riad BayoumiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.ORCID https://orcid.org/0000-0001-8177-8129
Muhammad FarooqiDubai Diabetes Center, Dubai Health, Dubai, UAE.
Fatheya AlawadiEndocrinology Department, Dubai Hospital, Dubai Health, Dubai, UAE.
Mohamed HassaneinEndocrinology Department, Dubai Hospital, Dubai Health, Dubai, UAE.
Aya OsamaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Debasmita MukhopadhyayCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Fatima AbdulCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Fatima SulaimanCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Stafny DsouzaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.ORCID https://orcid.org/0000-0001-5618-6930
Fahad MullaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Fayha AhmedPathology Department, Dubai Hospital, Dubai Health, Dubai, UAE.
Mouza AlSharhanPathology Department, Dubai Hospital, Dubai Health, Dubai, UAE.
Amar KhamisCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.ORCID https://orcid.org/0000-0002-8518-3066

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAttempts to subtype, type 2 diabetes (T2D) have mostly focused on newly diagnosed European patients. In this study, our aim was to subtype T2D in a non-white Emirati ethnic population with long-standing disease, using unsupervised soft clustering, based on etiological determinants.

methodsThe Auto Cluster model in the IBM SPSS Modeler was used to cluster data from 348 Emirati patients with long-standing T2D. Five predictor variables (fasting blood glucose (FBG), fasting serum insulin (FSI), body mass index (BMI), hemoglobin A1c (HbA1c) and age at diagnosis) were used to determine the appropriate number of clusters and their clinical characteristics. Multinomial logistic regression was used to validate clustering results.

resultsFive clusters were identified; the first four matched Ahlqvist et al subgroups: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and a fifth new subtype of mild early onset diabetes (MEOD). The Modeler algorithm allows for soft assignments, in which a data point can be assigned to multiple clusters with different probabilities. There were 151 patients (43%) with membership in cluster peaks with no overlap. The remaining 197 patients (57%) showed extensive overlap between clusters at the base of distributions.

conclusionsDespite the complex picture of long-standing T2D with comorbidities and complications, our study demonstrates the feasibility of identifying subtypes and their underlying causes. While clustering provides valuable insights into the architecture of T2D subtypes, its application to individual patient management would remain limited due to overlapping characteristics. Therefore, integrating simplified, personalized metabolic profiles with clustering holds greater promise for guiding clinical decisions than subtyping alone.

Indexed as

Diabetes Mellitus, Type 2AdultAgedBlood GlucoseBody Mass IndexCluster AnalysisFemaleGlycated HemoglobinHumansInsulinInsulin ResistanceMaleMiddle AgedUnited Arab EmiratesBlood GlucoseGlycated HemoglobinInsulin

Identifiers

PMID38805513
PMCPMC11132508

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.